Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing.

× No keyword cloud information.

150 in total

1. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver.

Authors: J K Reddy; M S Rao; D L Azarnoff; S Sell
Journal: Cancer Res Date: 1979-01 Impact factor: 12.701

2. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.

Authors: J K Reddy; D L Azarnoff; C E Hignite
Journal: Nature Date: 1980-01-24 Impact factor: 49.962

3. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.

Authors: J R Warren; V F Simmon; J K Reddy
Journal: Cancer Res Date: 1980-01 Impact factor: 12.701

4. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators.

Authors: J K Reddy; N D Lalwani; M K Reddy; S A Qureshi
Journal: Cancer Res Date: 1982-01 Impact factor: 12.701

5. Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds.

Authors: D E Moody; J K Reddy
Journal: Toxicol Appl Pharmacol Date: 1978-08 Impact factor: 4.219

6. The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643.

Authors: M S Rao; N D Lalwani; D G Scarpelli; J K Reddy
Journal: Carcinogenesis Date: 1982 Impact factor: 4.944

7. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.

Authors: N D Lalwani; M K Reddy; S A Qureshi; C R Sirtori; Y Abiko; J K Reddy
Journal: Hum Toxicol Date: 1983-01

8. Immunocytochemical localization of catalase and heat-labile enoyl-CoA hydratase in the livers of normal and peroxisome proliferator-treated rats.

Authors: M Bendayan; J K Reddy
Journal: Lab Invest Date: 1982-10 Impact factor: 5.662

9. Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute.

Authors: W M Kluwe; E E McConnell; J E Huff; J K Haseman; J F Douglas; W V Hartwell
Journal: Environ Health Perspect Date: 1982-11 Impact factor: 9.031

10. Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats.

Authors: J K Reddy; S A Qureshi
Journal: Br J Cancer Date: 1979-09 Impact factor: 7.640

16 in total

1. Novel peroxisomal protease Tysnd1 processes PTS1- and PTS2-containing enzymes involved in beta-oxidation of fatty acids.

Authors: Igor V Kurochkin; Yumi Mizuno; Akihiko Konagaya; Yoshiyuki Sakaki; Christian Schönbach; Yasushi Okazaki
Journal: EMBO J Date: 2007-01-25 Impact factor: 11.598

2. Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice.

Authors: Jiansheng Huang; Navin Viswakarma; Songtao Yu; Yuzhi Jia; Liang Bai; Aurore Vluggens; Mustapha Cherkaoui-Malki; Mushfiquddin Khan; Inderjit Singh; Gongshe Yang; M Sambasiva Rao; Jayme Borensztajn; Janardan K Reddy
Journal: Am J Pathol Date: 2011-06-12 Impact factor: 4.307

3. Localization of a portion of the liver isoform of fatty-acid-binding protein (L-FABP) to peroxisomes.

Authors: Vasily D Antonenkov; Raija T Sormunen; Steffen Ohlmeier; Leen Amery; Marc Fransen; Guy P Mannaerts; J Kalervo Hiltunen
Journal: Biochem J Date: 2006-03-01 Impact factor: 3.857

Review 4. Recent developments in polyfluoroalkyl compounds research: a focus on human/environmental health impact, suggested substitutes and removal strategies.

Authors: John Baptist Nzukizi Mudumbi; Seteno Karabo Obed Ntwampe; Tandi Matsha; Lukhanyo Mekuto; Elie Fereche Itoba-Tombo
Journal: Environ Monit Assess Date: 2017-07-18 Impact factor: 2.513

Review 5. PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors: Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal: Nucl Recept Signal Date: 2010-04-16

6. PRIC295, a Nuclear Receptor Coactivator, Identified from PPARα-Interacting Cofactor Complex.

Authors: Sean R Pyper; Navin Viswakarma; Yuzhi Jia; Yi-Jun Zhu; Joseph D Fondell; Janardan K Reddy
Journal: PPAR Res Date: 2010-09-05 Impact factor: 4.964

Review 7. Immune mechanisms and novel pharmacological therapies of acute kidney injury.

Authors: Amandeep Bajwa; Gilbert R Kinsey; Mark D Okusa
Journal: Curr Drug Targets Date: 2009-12 Impact factor: 3.465

8. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation.

Authors: Ruiyin Chu; Hanjo Lim; Laura Brumfield; Hong Liu; Chris Herring; Peter Ulintz; Janardan K Reddy; Matthew Davison
Journal: Mol Cell Biol Date: 2004-07 Impact factor: 4.272

9. Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver.

Authors: Joy Sarkar; Chao Qi; Dongsheng Guo; Mohamed R Ahmed; Yuzhi Jia; Nobuteru Usuda; Navin Viswakarma; M Sambasiva Rao; Janardan K Reddy
Journal: Gene Expr Date: 2007

10. Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice.

Authors: Craig E Wheelock; Susumu Goto; Bruce D Hammock; John W Newman
Journal: Metabolomics Date: 2007-06 Impact factor: 4.290